UA89963C2 - Tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs) - Google Patents
Tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs)Info
- Publication number
- UA89963C2 UA89963C2 UAA200701545A UAA200701545A UA89963C2 UA 89963 C2 UA89963 C2 UA 89963C2 UA A200701545 A UAA200701545 A UA A200701545A UA A200701545 A UAA200701545 A UA A200701545A UA 89963 C2 UA89963 C2 UA 89963C2
- Authority
- UA
- Ukraine
- Prior art keywords
- gpcrs
- improved
- ligands
- protein coupled
- coupled receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to novel tetrahydrocarbazole derivatives with improved properties, of application as inhibitors of GPCRs. The possibility is thus provided for the treatment with the novel compounds of disease states the expression of which depends on the pathological biochemical action of GPCRs. Said compounds have a particular antagonistic inhibition of the LHRH receptor. The invention further relates to medicaments comprising one or more of the novel compounds as active ingredient. The medicaments are particularly suitable for application in mammals and humans in oral dosage form.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004033902A DE102004033902A1 (en) | 2004-07-14 | 2004-07-14 | New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
UA89963C2 true UA89963C2 (en) | 2010-03-25 |
Family
ID=40951405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200701545A UA89963C2 (en) | 2004-07-14 | 2005-07-05 | Tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs) |
Country Status (2)
Country | Link |
---|---|
UA (1) | UA89963C2 (en) |
ZA (1) | ZA200609436B (en) |
-
2005
- 2005-07-05 UA UAA200701545A patent/UA89963C2/en unknown
-
2006
- 2006-11-13 ZA ZA200609436A patent/ZA200609436B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200609436B (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0515489A (en) | heterocyclic derivatives and their use as stearoyl coat desaturase inhibitors | |
CR7928A (en) | MEDICATION FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS AND HYPERTENSION | |
NO20064041L (en) | Substituted pyrazoline compositions, their preparation and use as drugs | |
NO20054407L (en) | Cannabinoid receptor ligands and their uses | |
CR8497A (en) | DERIVATIVES OF AZEPINOINDOL AS PHARMACEUTICAL AGENTS | |
NO20052512L (en) | Purine compounds and use deav as cannabinoid receptor ligands | |
JP2009507081A (en) | Regulation of neurogenesis by HDac inhibition | |
JP2009536667A (en) | 5HT receptor-mediated neurogenesis | |
WO2005072308A3 (en) | Cgrp receptor antagonists | |
CY1111977T1 (en) | PEPERIDIN-4-YL-PYRIDAZIN-3-YLAMINE DERIVATIVES AS HIGHLY DISTRIBUTED DOPAMIN COMPONENTS 2 | |
UY26130A1 (en) | COMPOUNDS TO TREAT OBESITY | |
CY1112376T1 (en) | 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists | |
BRPI0517438A (en) | compound, method for treating the condition associated with muscarinic m4 receptor activity, compound use, and, pharmaceutical composition | |
UA86621C2 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
NO20055631L (en) | Dosage form containing pantoprazole as active ingredient | |
BRPI0613664A8 (en) | 3-lactamyl phenylalanine, cysteine and serine antagonist vasopressin | |
DE602004011398D1 (en) | DIRECT COMPRESSIBLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CCI-779 | |
ATE412636T1 (en) | PIPERAZINYLPYRIDINE DERIVATIVES AS AN AGAINST OBESITY | |
DK1551803T3 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
NO20074933L (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
CY1113759T1 (en) | HIGHLY DISTRIBUTED DOPAMINE COMPETITORS 2 | |
TW200616955A (en) | Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of g-protein coupled receptors (gpcrs) | |
NO20091052L (en) | Diaryl ether derivatives and uses thereof | |
CL2007002511A1 (en) | COMPOSITES DERIVED FROM PIRROLO [2,3-F] ISOQUINOLINA, INHIBITORS OF KINASE-2; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE FOR THE TREATMENT OF AN AUTOIMMUNE DISEASE. | |
NZ597317A (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application |